Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | ACHE | P22303 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.37 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7811284 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL30058349 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL2502467 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL199961 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL29464227 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL138533 | 1.00 | TSHR (0.50) | TSHRACHEALDH1A1CA1CA2 | |
| Hydrochloric Acid SCHEMBL290288 | 0.97 | TSHR (0.47) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL29357701 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL4480 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 | |
| SCHEMBL3127305 | 0.97 | TSHR (0.53) | TSHRACHEALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011088-A | Cyclic peptide compound and preparation method and application thereof | 甫康生物科技(上海)股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-115151537-B | Process for preparing heterocyclic amine derivatives | 株式会社大熊制药 | 2024-09-06 | — | — | CN | claimed |
| CN-115677514-B | Fluorine-containing diamine monomer, polyimide film and preparation method | 中国科学院宁波材料技术与工程研究所 | 2024-08-09 | — | — | CN | claimed |
| CN-118290438-A | Diamine precursor, polyimide and transparent polyimide film based on spiro-bisxanthene structure and manufacturing method thereof | 大连理工大学 | 2024-07-05 | — | — | CN | claimed |
| CN-115677515-B | Diamine monomer, polyamide imide copolymer, polyamide imide film and preparation method | 中国科学院宁波材料技术与工程研究所 | 2024-03-29 | — | — | CN | claimed |
| CN-115536666-B | Dianhydride monomer containing benzobisnorbornene cyclobutane structure and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2024-01-26 | — | — | CN | claimed |
| CN-116178432-A | Novel preparation method of fosfomycin sodium | 鼎元(天津)生物医药科技有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115677514-A | Fluorine-containing diamine monomer, polyimide film and preparation method | 中国科学院宁波材料技术与工程研究所 | 2023-02-03 | — | — | CN | claimed |
| CN-115677515-A | Diamine monomer, polyamideimide copolymer, polyamideimide film and preparation method | 中国科学院宁波材料技术与工程研究所 | 2023-02-03 | — | — | CN | claimed |
| CN-115536666-A | Dianhydride monomer containing benzo-bisnorbornene cyclobutane structure and preparation method and application thereof | 中国科学院宁波材料技术与工程研究所 | 2022-12-30 | — | — | CN | claimed |
| CN-115151537-A | Process for preparing heterocyclic amine derivatives | 株式会社大熊制药 | 2022-10-04 | — | — | CN | claimed |
| CN-114956972-A | Novel synthesis method of buparvaquone | 沧州东恩科技有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-113264917-B | Anti-hepatitis B virus compound and preparation method and application thereof | 华南理工大学 | 2022-07-01 | — | — | CN | claimed |
| CN-122011088-A | Cyclic peptide compound and preparation method and application thereof | 甫康生物科技(上海)股份有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260116891-A1 | Oxazepin Derivative | TEIJIN PHARMA LTD (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4662274-A1 | PHOSPHINE LIGANDS AND THEIR USE IN COUPLING REACTIONS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| CN-114989000-A | Process for preparing unsaturated carboxylic acids by carbonylation of allyl alcohol and acylates thereof | 巴斯夫欧洲公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114956972-A | Novel synthesis method of buparvaquone | 沧州东恩科技有限公司 | 2022-08-30 | — | — | CN | disclosed |
| CN-113264917-B | Anti-hepatitis B virus compound and preparation method and application thereof | 华南理工大学 | 2022-07-01 | — | — | CN | disclosed |
| CN-110312701-B | Process for preparing unsaturated carboxylic acids by carbonylation of allyl alcohol and acylates thereof | 巴斯夫欧洲公司 | 2022-06-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116891-A1 | Oxazepin Derivative | HCRTR2, HCRTR1, OXTR | TSHR 166/4885ACHE 4644/4885ALDH1A1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.